Salem Capital Management Inc Abbott Laboratories Transaction History

Salem Capital Management Inc

$126 Million
Q3 2022

A detailed history of Salem Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Salem Capital Management Inc holds 16,096 shares of ABT stock, worth $1.85 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

16,096

Previous 16,096 -0.0%

Holding current value

$1.85 Million

Previous $1.75 Million 10.98%

% of portfolio

1.23%

Previous 1.28%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $23,884 - $28,868	-234 Reduced 1.43%	16,096 $1.75 Million
Q1 2022 Apr 07, 2022	SELL	$114.02 - $139.04 $37,968 - $46,300	-333 Reduced 2.0%	16,330 $1.93 Million
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $202,177 - $247,555	-1,750 Reduced 9.5%	16,663 $2.35 Million
Q3 2021 Oct 12, 2021	SELL	$116.66 - $129.06 $29,165 - $32,265	-250 Reduced 1.34%	18,413 $2.18 Million
Q2 2021 Jul 13, 2021	SELL	$105.79 - $124.53 $118,484 - $139,473	-1,120 Reduced 5.66%	18,663 $2.16 Million
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $21,768 - $25,645	-200 Reduced 1.0%	19,783 $2.37 Million
Q4 2020 Jan 12, 2021	SELL	$105.0 - $114.42 $31,500 - $34,326	-300 Reduced 1.48%	19,983 $2.19 Million
Q3 2020 Oct 13, 2020	SELL	$91.64 - $111.29 $93,931 - $114,072	-1,025 Reduced 4.81%	20,283 $2.21 Million
Q4 2019 Jan 09, 2020	SELL	$78.51 - $87.4 $73,563 - $81,893	-937 Reduced 4.21%	21,308 $1.85 Million
Q3 2019 Oct 07, 2019	SELL	$81.84 - $88.74 $16,368 - $17,748	-200 Reduced 0.89%	22,245 $1.86 Million
Q1 2019 Apr 15, 2019	SELL	$66.22 - $80.06 $66,220 - $80,060	-1,000 Reduced 4.27%	22,445 $1.79 Million
Q4 2018 Jan 08, 2019	SELL	$65.56 - $74.27 $13,112 - $14,854	-200 Reduced 0.85%	23,445 $1.7 Million
Q3 2018 Oct 09, 2018	SELL	$60.81 - $73.36 $30,405 - $36,680	-500 Reduced 2.07%	23,645 $1.74 Million
Q2 2018 Jul 09, 2018	SELL	$57.57 - $63.54 $40,299 - $44,478	-700 Reduced 2.82%	24,145 $1.47 Million
Q1 2018 Apr 09, 2018	SELL	$56.27 - $63.62 $56,270 - $63,620	-1,000 Reduced 3.87%	24,845 $1.49 Million
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $285,792 - $305,970	-5,324 Reduced 17.08%	25,845 $1.48 Million
Q3 2017 Oct 10, 2017	BUY	$48.06 - $53.64 $1.5 Million - $1.67 Million	31,169	31,169 $1.66 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.

Account

Salem Capital Management Inc Abbott Laboratories Transaction History